KATE O'FARRELL: Open Payments
NPI 1750053526 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$472 in 24 payments from 9 companies in 2025. Trend: 2023 $1,384 · 2024 $944 · 2025 $472
Food & beverage: $472
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 8 | $137 |
| E.R. Squibb & Sons, L.L.C. | 4 | $83 |
| Vanda Pharmaceuticals Inc. | 3 | $57 |
| Corium, LLC | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Alkermes, Inc. | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $15 |
Products named: ABILIFY MAINTENA, COBENFY, FANAPT, Azstarys, ABILIFY ASIMTUFII, REXULTI, Jornay PM, VIVITROL.
Industry payments across IN — which companies pay providers there.
